C B PHARMA ACQUISITION CORP

Q2 2015 13F Holders

CUSIP
G2029P134
Type
Equity
Class
RIGHT 06/17/2016
Num filings
4
Total reported value, excl. options
$323 k
Manager Report Date Value ($000) Shares Option Type